Do analysts recommend TROO or UPXI?

Upexi has a consensus target price of $4.65, suggesting a potential upside of 338.68%. Given Upexi's stronger consensus rating and higher probable upside, analysts plainly believe Upexi is more favorable than TROOPS. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TROOPS 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Upexi 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has better earnings & valuation, TROO or UPXI?

Upexi has lower revenue, but higher earnings than TROOPS. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TROOPS $17.10M 14.14 -$27.91M N/A N/A Upexi $15.81M 5.28 -$13.68M -$0.62 N/A

Is TROO or UPXI more profitable?

TROOPS has a net margin of 0.00% compared to Upexi's net margin of -874.00%. TROOPS's return on equity of 0.00% beat Upexi's return on equity. Company Net Margins Return on Equity Return on Assets TROOPS N/A N/A N/A Upexi -874.00% -66.70% -19.56%

Does the media refer more to TROO or UPXI?

In the previous week, TROOPS had 6 more articles in the media than Upexi. MarketBeat recorded 9 mentions for TROOPS and 3 mentions for Upexi. Upexi's average media sentiment score of 0.62 beat TROOPS's score of -0.47 indicating that Upexi is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TROOPS 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 4 Negative mention(s) 2 Very Negative mention(s) Neutral Upexi 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate CNTN or UPXI?

Upexi has a consensus price target of $4.65, suggesting a potential upside of 338.68%. Given Upexi's stronger consensus rating and higher probable upside, analysts clearly believe Upexi is more favorable than Hillstream Biopharma. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hillstream Biopharma 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Upexi 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Does the media favor CNTN or UPXI?

In the previous week, Hillstream Biopharma and Hillstream Biopharma both had 3 articles in the media. Hillstream Biopharma's average media sentiment score of 0.62 equaled Upexi'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hillstream Biopharma 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Upexi 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend UPXI or TONX?

Upexi presently has a consensus target price of $4.65, suggesting a potential upside of 338.68%. Given Upexi's stronger consensus rating and higher possible upside, equities analysts plainly believe Upexi is more favorable than Verb Technology. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Upexi 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Verb Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation and earnings, UPXI or TONX?

Upexi has higher revenue and earnings than Verb Technology. Verb Technology is trading at a lower price-to-earnings ratio than Upexi, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Upexi $15.81M 5.28 -$13.68M -$0.62 N/A Verb Technology $12.78M 12.84 -$148.48M -$1.04 N/A

Is UPXI or TONX more profitable?

Verb Technology has a net margin of -497.15% compared to Upexi's net margin of -874.00%. Verb Technology's return on equity of -60.82% beat Upexi's return on equity. Company Net Margins Return on Equity Return on Assets Upexi -874.00% -66.70% -19.56% Verb Technology -497.15% -60.82% -59.56%

Do analysts recommend BNC or UPXI?

Upexi has a consensus target price of $4.65, indicating a potential upside of 338.68%. Given Upexi's stronger consensus rating and higher possible upside, analysts clearly believe Upexi is more favorable than CEA Industries. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CEA Industries 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Upexi 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable earnings and valuation, BNC or UPXI?

CEA Industries has higher revenue and earnings than Upexi. Upexi is trading at a lower price-to-earnings ratio than CEA Industries, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CEA Industries $29.33M 4.10 $115.26M $5.65 0.52 Upexi $15.81M 5.28 -$13.68M -$0.62 N/A

Is BNC or UPXI more profitable?

CEA Industries has a net margin of 392.91% compared to Upexi's net margin of -874.00%. CEA Industries' return on equity of 81.62% beat Upexi's return on equity. Company Net Margins Return on Equity Return on Assets CEA Industries 392.91% 81.62% 67.22% Upexi -874.00% -66.70% -19.56%

Which has preferable earnings and valuation, UPXI or HSDT?

Upexi has higher revenue and earnings than Solana. Upexi is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Upexi $15.81M 5.28 -$13.68M -$0.62 N/A Solana $6.02M 20.59 -$40.89M -$30.32 N/A

Is UPXI or HSDT more profitable?

Upexi has a net margin of -874.00% compared to Solana's net margin of -1,302.78%. Solana's return on equity of -41.86% beat Upexi's return on equity. Company Net Margins Return on Equity Return on Assets Upexi -874.00% -66.70% -19.56% Solana -1,302.78% -41.86% -18.53%

Does the media prefer UPXI or HSDT?

In the previous week, Solana had 2 more articles in the media than Upexi. MarketBeat recorded 5 mentions for Solana and 3 mentions for Upexi. Upexi's average media sentiment score of 0.62 beat Solana's score of 0.31 indicating that Upexi is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Upexi 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Solana 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Upexi (UPXI) Competitors

$1.06 -0.03 (-2.75%)

As of 08/26/2026 04:00 PM Eastern

Compare

UPXI vs. TROO, CNTN, TONX, BNC, and HSDT

Should you buy Upexi stock or one of its competitors? Upexi's main competitors and comparable companies include TROOPS (TROO), Hillstream Biopharma (CNTN), Verb Technology (TONX), CEA Industries (BNC), and Solana (HSDT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "multi-sector holdings" industry.

How does Upexi compare to TROOPS?

TROOPS (NASDAQ:TROO) and Upexi (NASDAQ:UPXI) are both small-cap finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

TROOPS has a net margin of 0.00% compared to Upexi's net margin of -874.00%. TROOPS's return on equity of 0.00% beat Upexi's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TROOPS	N/A	N/A	N/A
Upexi	-874.00%	-66.70%	-19.56%

In the previous week, TROOPS had 6 more articles in the media than Upexi. MarketBeat recorded 9 mentions for TROOPS and 3 mentions for Upexi. Upexi's average media sentiment score of 0.62 beat TROOPS's score of -0.47 indicating that Upexi is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TROOPS	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	4 Negative mention(s)	2 Very Negative mention(s)	Neutral
Upexi	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

5.7% of Upexi shares are owned by institutional investors. 1.1% of TROOPS shares are owned by insiders. Comparatively, 9.0% of Upexi shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Upexi has lower revenue, but higher earnings than TROOPS.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TROOPS	$17.10M	14.14	-$27.91M	N/A	N/A
Upexi	$15.81M	5.28	-$13.68M	-$0.62	N/A

TROOPS has a beta of 3.49, suggesting that its stock price is 249% more volatile than the broader market. Comparatively, Upexi has a beta of -0.27, suggesting that its stock price is 127% less volatile than the broader market.

Upexi has a consensus target price of $4.65, suggesting a potential upside of 338.68%. Given Upexi's stronger consensus rating and higher probable upside, analysts plainly believe Upexi is more favorable than TROOPS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TROOPS	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Upexi	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Summary

TROOPS and Upexi tied by winning 7 of the 14 factors compared between the two stocks.

How does Upexi compare to Hillstream Biopharma?

Hillstream Biopharma (NASDAQ:CNTN) and Upexi (NASDAQ:UPXI) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

1.2% of Hillstream Biopharma shares are held by institutional investors. Comparatively, 5.7% of Upexi shares are held by institutional investors. 3.3% of Hillstream Biopharma shares are held by company insiders. Comparatively, 9.0% of Upexi shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Upexi has a consensus price target of $4.65, suggesting a potential upside of 338.68%. Given Upexi's stronger consensus rating and higher probable upside, analysts clearly believe Upexi is more favorable than Hillstream Biopharma.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hillstream Biopharma	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Upexi	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Hillstream Biopharma has a beta of 1.45, meaning that its share price is 45% more volatile than the broader market. Comparatively, Upexi has a beta of -0.27, meaning that its share price is 127% less volatile than the broader market.

Hillstream Biopharma has a net margin of 0.00% compared to Upexi's net margin of -874.00%. Hillstream Biopharma's return on equity of -20.06% beat Upexi's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hillstream Biopharma	N/A	-20.06%	-15.90%
Upexi	-874.00%	-66.70%	-19.56%

In the previous week, Hillstream Biopharma and Hillstream Biopharma both had 3 articles in the media. Hillstream Biopharma's average media sentiment score of 0.62 equaled Upexi'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hillstream Biopharma	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Upexi	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Upexi has higher revenue and earnings than Hillstream Biopharma. Hillstream Biopharma is trading at a lower price-to-earnings ratio than Upexi, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hillstream Biopharma	N/A	N/A	-$35.92M	-$0.50	N/A
Upexi	$15.81M	5.28	-$13.68M	-$0.62	N/A

Summary

Upexi beats Hillstream Biopharma on 8 of the 13 factors compared between the two stocks.

How does Upexi compare to Verb Technology?

Upexi (NASDAQ:UPXI) and Verb Technology (NASDAQ:TONX) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations.

5.7% of Upexi shares are owned by institutional investors. Comparatively, 7.2% of Verb Technology shares are owned by institutional investors. 9.0% of Upexi shares are owned by insiders. Comparatively, 21.4% of Verb Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Upexi presently has a consensus target price of $4.65, suggesting a potential upside of 338.68%. Given Upexi's stronger consensus rating and higher possible upside, equities analysts plainly believe Upexi is more favorable than Verb Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Upexi	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Verb Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Upexi has a beta of -0.27, suggesting that its share price is 127% less volatile than the broader market. Comparatively, Verb Technology has a beta of 0.68, suggesting that its share price is 32% less volatile than the broader market.

Upexi has higher revenue and earnings than Verb Technology. Verb Technology is trading at a lower price-to-earnings ratio than Upexi, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Upexi	$15.81M	5.28	-$13.68M	-$0.62	N/A
Verb Technology	$12.78M	12.84	-$148.48M	-$1.04	N/A

Verb Technology has a net margin of -497.15% compared to Upexi's net margin of -874.00%. Verb Technology's return on equity of -60.82% beat Upexi's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Upexi	-874.00%	-66.70%	-19.56%
Verb Technology	-497.15%	-60.82%	-59.56%

In the previous week, Upexi had 2 more articles in the media than Verb Technology. MarketBeat recorded 3 mentions for Upexi and 1 mentions for Verb Technology. Verb Technology's average media sentiment score of 1.87 beat Upexi's score of 0.62 indicating that Verb Technology is being referred to more favorably in the news media.

Company	Overall Sentiment
Upexi	Positive
Verb Technology	Very Positive

Summary

Upexi beats Verb Technology on 9 of the 16 factors compared between the two stocks.

How does Upexi compare to CEA Industries?

CEA Industries (NASDAQ:BNC) and Upexi (NASDAQ:UPXI) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, valuation, profitability, risk, media sentiment and dividends.

CEA Industries has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market. Comparatively, Upexi has a beta of -0.27, indicating that its share price is 127% less volatile than the broader market.

CEA Industries has higher revenue and earnings than Upexi. Upexi is trading at a lower price-to-earnings ratio than CEA Industries, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CEA Industries	$29.33M	4.10	$115.26M	$5.65	0.52
Upexi	$15.81M	5.28	-$13.68M	-$0.62	N/A

Upexi has a consensus target price of $4.65, indicating a potential upside of 338.68%. Given Upexi's stronger consensus rating and higher possible upside, analysts clearly believe Upexi is more favorable than CEA Industries.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CEA Industries	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Upexi	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

CEA Industries has a net margin of 392.91% compared to Upexi's net margin of -874.00%. CEA Industries' return on equity of 81.62% beat Upexi's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CEA Industries	392.91%	81.62%	67.22%
Upexi	-874.00%	-66.70%	-19.56%

In the previous week, Upexi had 2 more articles in the media than CEA Industries. MarketBeat recorded 3 mentions for Upexi and 1 mentions for CEA Industries. CEA Industries' average media sentiment score of 1.87 beat Upexi's score of 0.62 indicating that CEA Industries is being referred to more favorably in the media.

Company	Overall Sentiment
CEA Industries	Very Positive
Upexi	Positive

5.7% of Upexi shares are owned by institutional investors. 2.7% of CEA Industries shares are owned by insiders. Comparatively, 9.0% of Upexi shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

CEA Industries beats Upexi on 9 of the 16 factors compared between the two stocks.

How does Upexi compare to Solana?

Upexi (NASDAQ:UPXI) and Solana (NASDAQ:HSDT) are both small-cap finance companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

In the previous week, Solana had 2 more articles in the media than Upexi. MarketBeat recorded 5 mentions for Solana and 3 mentions for Upexi. Upexi's average media sentiment score of 0.62 beat Solana's score of 0.31 indicating that Upexi is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Upexi	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Solana	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Upexi has a beta of -0.27, meaning that its share price is 127% less volatile than the broader market. Comparatively, Solana has a beta of 1.01, meaning that its share price is 1% more volatile than the broader market.

Upexi has higher revenue and earnings than Solana. Upexi is trading at a lower price-to-earnings ratio than Solana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Upexi	$15.81M	5.28	-$13.68M	-$0.62	N/A
Solana	$6.02M	20.59	-$40.89M	-$30.32	N/A

Upexi presently has a consensus price target of $4.65, suggesting a potential upside of 338.68%. Solana has a consensus price target of $3.25, suggesting a potential upside of 58.54%. Given Upexi's higher possible upside, analysts plainly believe Upexi is more favorable than Solana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Upexi	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Solana	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Upexi has a net margin of -874.00% compared to Solana's net margin of -1,302.78%. Solana's return on equity of -41.86% beat Upexi's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Upexi	-874.00%	-66.70%	-19.56%
Solana	-1,302.78%	-41.86%	-18.53%

5.7% of Upexi shares are owned by institutional investors. Comparatively, 18.6% of Solana shares are owned by institutional investors. 9.0% of Upexi shares are owned by insiders. Comparatively, 14.4% of Solana shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Solana beats Upexi on 10 of the 16 factors compared between the two stocks.

Get Upexi News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UPXI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

UPXI vs. The Competition

Export

Metric	Upexi	Financial Services Industry	Finance Sector	NASDAQ Exchange
Market Cap	$85.79M	$27.38B	$14.10B	$12.81B
Dividend Yield	N/A	6.02%	5.89%	11.02%
P/E Ratio	-1.71	19.96	26.71	24.12
Price / Sales	5.28	437.86	518.88	89.48
Price / Cash	N/A	159.78	39.14	53.65
Price / Book	1.05	3.21	2.18	6.20
Net Income	-$13.68M	$1.09B	$1.31B	$348.07M
7 Day Performance	13.58%	10.16%	1.51%	1.11%
1 Month Performance	24.96%	12.19%	2.56%	4.27%
1 Year Performance	-87.10%	-1.58%	11.59%	16.48%

Upexi Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
UPXI Upexi	1.5051 of 5 stars	$1.06 -2.8%	$4.65 +338.7%	-87.6%	$85.79M	$15.81M	N/A	130	News Coverage Upcoming Earnings Gap Down
TROO TROOPS	0.1945 of 5 stars	$1.97 -1.5%	N/A	+76.8%	$240.66M	$17.10M	N/A	20
CNTN Hillstream Biopharma	0.644 of 5 stars	$2.01 -1.0%	N/A	N/A	$155.01M	N/A	N/A	2	Analyst Upgrade
TONX Verb Technology	1.3556 of 5 stars	$2.62 -7.1%	N/A	N/A	$144.29M	$30.80M	N/A	170	Positive News
BNC CEA Industries	0.9164 of 5 stars	$2.54 flat	N/A	N/A	$104.58M	$27.99M	0.45	30	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:UPXI) was last updated on 8/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Upexi (UPXI) Competitors

UPXI vs. TROO, CNTN, TONX, BNC, and HSDT

How does Upexi compare to TROOPS?

Summary

How does Upexi compare to Hillstream Biopharma?

Summary

How does Upexi compare to Verb Technology?

Summary

How does Upexi compare to CEA Industries?

Summary

How does Upexi compare to Solana?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UPXI vs. The Competition

Upexi Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Upexi (UPXI) Competitors

UPXI vs. TROO, CNTN, TONX, BNC, and HSDT

How does Upexi compare to TROOPS?

Is TROO or UPXI more profitable?

Does the media refer more to TROO or UPXI?

Do insiders and institutionals hold more shares of TROO or UPXI?

Which has better earnings & valuation, TROO or UPXI?

Which has more risk & volatility, TROO or UPXI?

Do analysts recommend TROO or UPXI?

Summary

How does Upexi compare to Hillstream Biopharma?

Do insiders & institutionals hold more shares of CNTN or UPXI?

Do analysts rate CNTN or UPXI?

Which has more volatility and risk, CNTN or UPXI?

Is CNTN or UPXI more profitable?

Does the media favor CNTN or UPXI?

Which has better valuation and earnings, CNTN or UPXI?

Summary

How does Upexi compare to Verb Technology?

Do institutionals and insiders hold more shares of UPXI or TONX?

Do analysts recommend UPXI or TONX?

Which has more volatility and risk, UPXI or TONX?

Which has preferable valuation and earnings, UPXI or TONX?

Is UPXI or TONX more profitable?

Does the media refer more to UPXI or TONX?

Summary

How does Upexi compare to CEA Industries?

Which has more volatility & risk, BNC or UPXI?

Which has preferable earnings and valuation, BNC or UPXI?

Do analysts recommend BNC or UPXI?

Is BNC or UPXI more profitable?

Does the media favor BNC or UPXI?

Do insiders & institutionals believe in BNC or UPXI?

Summary

How does Upexi compare to Solana?

Does the media prefer UPXI or HSDT?

Which has more volatility and risk, UPXI or HSDT?

Which has preferable earnings and valuation, UPXI or HSDT?

Do analysts prefer UPXI or HSDT?

Is UPXI or HSDT more profitable?

Do insiders and institutionals hold more shares of UPXI or HSDT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

UPXI vs. The Competition

Upexi Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools